sentences:
Transmission dynamics and vaccination strategies for Crimean-Congo haemorrhagic fever virus in Afghanistan: a modelling study BackgroundCrimean-Congo haemorrhagic fever virus (CCHFV) is a highly pathogenic virus for which a safe and effective vaccine is not yet available, despite being considered a priority emerging pathogen. Understanding transmission patterns and the use of potential effective vaccines are central elements of the future plan against this infection.

MethodsWe developed a series of models of transmission amongst livestock, and spillover infection into humans. We use real-world human and animal data from a CCHFV endemic area in Afghanistan (Herat) to calibrate our models. We assess the value of environmental drivers as proxy indicators of vector activity, and select the best model using deviance information criteria. Finally we assess the impact of vaccination by simulating campaigns targeted to humans or livestock, and to high-risk subpopulations (i.e, farmers).

FindingsSaturation deficit is the indicator that better explains tick activity trends in Herat. Recent increments in reported CCHFV cases in this area are more likely explained by increased surveillance capacity instead of changes in the background transmission dynamics. Modelling suggests that clinical cases only represent 31% (95% CrI 28%-33%) of total infections in this area. Vaccination campaigns targeting humans would result in a much larger impact than livestock vaccination (266 vs 31 clinical cases averted respectively) and a more efficient option when assessed in courses per case averted (35 vs 431 respectively). Targeted vaccination to farmers is impactful and more efficient, resulting in 19 courses per case averted (95% CrI 7-62) compared to targeting the general population (35 95% CrI 16-107)

InterpretationCCHFV is endemic in Herat, and transmission cycles are well predicted by environmental drivers like saturation deficit. Vaccinating humans is likely to be more efficient and impactful than animals, and importantly targeted interventions to high risk groups like farmers can offer a more efficient approach to vaccine roll-out.

FundingW.J.E., JFV and MHAC were funded by the Department of Health and Social Care using UK Aid funding managed by the National Institute for Health Research (Vaccine Efficacy Evaluation for Priority Emerging Diseases: PR-OD-1017-20002). The views expressed in this publication are those of the authors and not necessarily those of the Department of Health and Social Care.


sentences:
Analysis of clinical trial registry entry histories using the novel R package cthist Historical clinical trial registry data can only be retrieved by manually accessing individual clinical trials through registry websites. This limits the feasibility, accuracy and reproducibility of certain kinds of research on clinical trial activity and presents challenges to the transparency of the enterprise of human research. This paper presents cthist, a novel, free and open source R package that enables mass downloading of clinical trial registry entry histories and returns structured data for analysis.

Documentation of the implementation of the package cthist is provided, as well as 3 brief case studies with example code.

labels: epidemiology


sentences:
The Global case-fatality rate of COVID-19 has been declining disproportionately between top vaccinated countries and the rest of the world Globally 58.83% human population received at least one dose of the COVID-19 vaccines as of 5 January 2021. COVID-19 vaccination rollout is progressing at varied rates globally and data on the impact of mass vaccination on infection and case-fatality rates require definition. We compared the global reported cumulative case-fatality rate (rCFR) between top-20 countries with COVID-19 vaccination rates (>125 doses/100 people) and the rest of the world, before and after commencement of vaccination programmes.

We considered the 28th day of receiving the first vaccine in the world as a cut-off to compare the pre-vaccine period (Jan 1, 2020 - Jan 5, 2021) and the post-vaccine period (Jan 6, 2021-Jan 5, 2022). We used a Generalized linear mixed model (GLMM) with a beta distribution to investigate the association between the CFR and potential predictors of each country and reported the relative risk (RR) of each variable.

The mean rCFR of COVID-19 in the top-20 countries with vaccination rates was 1.83 (95% CI: 1.24-2.43) on 5 Jan 2021 and 1.18 (95% CI: 0.73-1.62) on 5 Jan 2022. The CFR for the rest of the world on 5 Jan 2021 was 2.32 (95% CI: 1.86-2.79) and 2.20 (95% CI: 1.86-2.55) on 5 January 2022. In Sub-Saharan Africa, the CFR remained roughly unchanged at 1.97 (95% CI: 1.59-2.35) on 5 Jan 2021 and 1.98 (95% CI:1.58-2.37) on 5 Jan 2022. The GLMM showed vaccination (/100 population) (RR:0.37) and Stringency Index (RR:0.88) were strong protective factors for the countrys COVID-19 CFR indicating that both vaccination and lockdown measures help in the reduction of COVID-19 CFR.

The rCFR of COVID-19 continues to decline, although at a disproportionate rate between top vaccinated countries and the rest of the world. Vaccine equity and faster roll-out across the world is critically important in reducing COVID-19 transmission and CFR.

Key Questions

What is already knownO_LIVaccination can reduce the case-fatality rate of COVID-19. Globally, the COVID-19 vaccination rollout is progressing at varied rates.
C_LI

What are the new findingsO_LIIn the top-20 countries with vaccination, >200 doses of vaccines are given per 100 people on 5th Jan 2022, In the rest of the word, the figure is 105, and in Sub-Saharan Africa (SSA) only 15.72
C_LIO_LIAfter the introduction of COVID-19 vaccination the reported case-fatality rate (rCFR) of COVID-19 has reduced by 35% in the top-20 countries with vaccination, 8% in the rest of the world roughly unchanged in SSA.
C_LIO_LIThe doses of COVID-19 vaccines (/100 people) and rCFR has a negative correlation on 5 Jan 2022 (r=-0.296, p<0.001).
C_LIO_LIThe COVID-19 vaccination and Stringency Index are strong protective factors for the countrys COVID-19 rCFR indicating that both vaccination and lockdown measures help in reduction of COVID-19 rCFR.
C_LI

What do the new findings implyO_LIThe disproportionate case-fatality rate of COVID-19 between top vaccinated countries and the rest of the world demand fast and equitable vaccine rollout globally to reduce COVID-19 transmission and CFR
C_LI


sentences: The Impact of Frequent SARS-CoV-2 Testing on Weekly Case Rates Among Long-Term Care Facilities in Florida SARS-CoV-2 testing frequency may be as important as test performance for disease control. We analyzed 1,292,165 SARS-CoV-2 test results among 361 long-term care facilities across Florida after implementing twice monthly testing (June 2020-April 2021). Our findings demonstrate that an increase in testing frequency reduced weekly case rates.


sentences: The impact of recurrent rapid test strategies on the effectiveness of at-home antiviral treatments for SARS-CoV-2 As has been consistently demonstrated, rapid tests administered at regular intervals can offer significant benefits to both individuals and their communities at large by helping identify whether an individual is infected and potentially infectious. An additional advantage to the individual is that positive tests may be provided sufficiently early enough during their infection that treatment with antiviral treatments can effectively inhibit development of severe disease, particularly when PCR uptake is limited and delays to receipt of results are substantial. Here, we provide a quantitative illustration of the extent to which rapid tests administered at various intervals can deliver benefits accrued from the novel Pfizer treatment (Paxlovid). We find that strategies for which tests are administered more routinely, i.e. every other day or once every three days, are associated with greater reductions in the risk of hospitalization and correspondingly, higher proportions of the infected population benefiting from treatment. We further observed that reduced positive-test-to-treatment delays and increased treatment coverage have a critical influence on average treatment benefits, signaling the importance of treatment access.


sentences:
Elevated COVID-19 Case Rates of Government Employees, District of Columbia, 2020-22 The rate ratios of COVID-19 cases among 5 District of Columbia departments personnel with reference to D.C. residents were found greater than one from March 2020 to early January 2022, suggesting higher case rates for emergency responders and frontline personnel than for general population. Vaccination is highly recommended.

Article summary lineGovernment employees from five D.C. departments, especially fire fighters and police officers, experienced higher COVID-19 case rates than D.C. residents.


sentences:
Hypnosis and music interventions for pain, anxiety, sleep, and well-being in palliative care: a systematic review and meta-analysis BackgroundMaintaining quality of life is a primary goal of palliative care (PC). Complementary interventions can help meet the needs of patients at the end of life.

ObjectivesThis meta-analysis aims to 1) evaluate the feasibility, acceptability, and fidelity of music and hypnosis interventions designed for patients in PC; 2) evaluate the impact of these interventions on pain, anxiety, sleep, and well-being.

MethodsRelevant studies were sourced from major databases. We selected both randomised controlled trials (RCT) and studies relying on pre-post design with details of the intervention(s).

ResultsFour RCT and seven non-randomised pre-post studies met the inclusion criteria. Overall, the feasibility and acceptability of the interventions reached an adequate level of satisfaction. However, only three studies reported using a written protocol. The meta-analysis of RCT indicated a significant decrease in pain with an effect size of -0.42, p = .003. The small number of RCT studies did not allow us to quantify the effects for other variables. Analyses of data from pre-post designs indicated a favourable outcome for pain, anxiety, sleep, and well-being.

ConclusionDespite the limited number of studies included in our meta-analysis, hypnosis and music intervention in the context of PC shows promising results in terms of feasibility and acceptability, as well as improvements on pain, anxiety, sleep and well-being. The available studies are insufficient to compare the efficacy across interventions and assess the potential benefits of their combinations. These results underscore the importance of further research on well-described complementary interventions relying on hypnosis and music.

Key Messages Box O_TEXTBOXWhat was already known?O_LIThere is a need for validated complementary palliative care interventions.
C_LIO_LIMusic and hypnosis intervention have shown significant effects for pain, anxiety, sleep, and well-being management in many populations.
C_LI

What are the new findings?O_LIHypnosis and music interventions show medium effect size for pain reduction in palliative care.
C_LIO_LIThe preliminary analysis of pre-post data shown promising results for pain, anxiety, sleep, and well-being in palliative care.
C_LI

What is their significance?O_LIThe good feasibility and acceptability of these interventions justify their use in clinical settings.
C_LIO_LIMore RCT studies with manualised interventions are needed to standardise the procedures, determine effect size and allow for a systematic comparison across interventions.
C_LI

C_TEXTBOX

labels: palliative medicine


sentences:
PBPK-led guidance for the treatment of cystic fibrosis patients taking elexacaftor-tezacaftor-ivacaftor with the newly approved fixed dose combination nirmatrelvir-ritonavir (PAXLOVID) for the treatment of COVID-19 BackgroundCystic fibrosis transmembrane conductance regulator (CFTR) modulating therapies including elexacaftor, tezacaftor, and ivacaftor (ETI) are primarily eliminated through cytochrome P450 (CYP) 3A-mediated metabolism. This creates a therapeutic challenge to the treatment of COVID-19 with nirmatrelvir-ritonavir in people with cystic fibrosis (pwCF) due to the potential for significant drug-drug interactions (DDI). However, pwCF are more at risk of serious illness following COVID-19 infection and hence it is important to manage the DDI risk and provide treatment options.

MethodsCYP3A-mediated DDI of ETI was evaluated using a physiologically based pharmacokinetic (PBPK) modeling approach. Modeling was performed incorporating physiological information and drug dependent parameters of ETI to predict the effect of ritonavir (the CYP3A4 inhibiting component of the combination) on pharmacokinetics of ETI. The ETI models were verified using independent clinical pharmacokinetic and DDI data of ETI with a range of CYP3A modulators.

ResultsWhen ritonavir was administered on day 1 through 5, the predicted AUC ratio of ivacaftor (the most sensitive CYP3A substrate) on day 6 was 9.31, indicating that its metabolism was strongly inhibited. Based on the predicted DDI, the dose of ETI should be reduced when co-administered with nirmatrelvir-ritonavir to elexacaftor 200mg-tezacaftor 100mg-ivacaftor 150mg on days 1 and 5, with resumption of full dose ETI on day 9, considering the residual inhibitory effect of ritonavir as a mechanism-based inhibitor.

ConclusionsCoadministration of nirmatrelvir-ritonavir requires a significant reduction in the ETI dosing frequency with delayed resumption of full dose due to the mechanism-based inhibition with ritonavir.

labels: pharmacology and therapeutics


sentences:
A systematic review of the factors associated with suicide attempts among sexual-minority adolescents IntroductionSuicide attempt is a worldwide major public health problem, that accounts for 1.4% of all deaths worldwide Recent literature reported higher risk of suicide attempt among adolescents associated with sexual minority status but few systematic reviews focused on the risk and protective factors. For that reason, it seems necessary to examine risk and protective factors of attempted suicide in sexual minority adolescents.

MethodsWe conducted a systematic review of published studies on factors associated with suicide attempts in LGBT adolescents. 4 databases up to December 2020 were searched to find relevant studies.

ResultsIn addition to the factors usually found in general population (gender, ethnic minorities, childhood trauma, psychiatric symptoms, addictive behaviors), some factors have been independently associated with suicide attempt in LGBT population: early coming out, not acceptable by families, not satisfied with LGBT friendship, too few number of friends, physical abuse, sexual abuse and bullying. The protective factors of suicide attempt reported in LGBT population were feeling safety at school, teacher support, anti-bullying policy, and other adults support.

ConclusionEffective preventive measures for suicide attempt among LGBT youth need to be developed and implemented. The impact of interventions targeting teacher responses to LGBT stigma, discussion of LGBT issues in class and reactions of family and friends to the coming out of LGBT youth should be further investigated.

labels: psychiatry and clinical psychology


sentences:
Aerosol measurement identifies SARS-CoV 2 PCR positive adults compared with healthy controls BackgroundSARS-CoV-2 is spread primarily through droplets and aerosols. Exhaled aerosols are generated in the lung periphery by  reopening of collapsed airways. Aerosol measuring may detect highly contagious individuals ("super spreaders or super-emitters") and discriminate between SARS-CoV-2 infected and non-infected individuals. This is the first study comparing exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls.

DesignA prospective observational cohort study in 288 adults, comprising 64 patients testing positive by SARS CoV-2 PCR before enrollment, and 224 healthy adults testing negative (matched control sample) at the University Hospital Frankfurt, Germany, from February to June 2021. Study objective was to evaluate the concentration of exhaled aerosols during physiologic breathing in SARS-CoV-2 PCR-positive and -negative subjects. Secondary outcome measures included correlation of aerosol concentration to SARS-CoV-2 PCR results, change in aerosol concentration due to confounders, and correlation between clinical symptoms and aerosol.

ResultsThere was a highly significant difference in respiratory aerosol concentrations between SARS-CoV-2 PCR-positive (median 1490.5/L) and -negative subjects (median 252.0/L; p<0.0001). There were no significant differences due to age, sex, smoking status, or body mass index. ROC analysis showed an AUC of 0.8918.

ConclusionsMeasurements of respiratory aerosols were significantly elevated in SARS-CoV-2 positive individuals and may become a helpful tool in detecting highly infectious individuals via a noninvasive breath test.

Clinical Trial NumberClinicalTrials.gov Identifier: NCT04739020.

Summary of the main pointIn this prospective, comparative cohort study, higher numbers of exhaled respiratory aerosols correlate with a positive PCR test for SARS-CoV-2. Measurement of exhaled aerosols may become a helpful tool in detecting contagious individuals via a readily available breath test.

labels: respiratory medicine


sentences: Virtual Epileptic Patient (VEP): Data-driven probabilistic personalized brain modeling in drug-resistant epilepsy One-third of 50 million epilepsy patients worldwide suffer from drug resistant epilepsy and are candidates for surgery. Precise estimates of the epileptogenic zone networks (EZNs) are crucial for planning intervention strategies. Here, we present the Virtual Epileptic Patient (VEP), a multimodal probabilistic modeling framework for personalized end-to-end analysis of brain imaging data of drug resistant epilepsy patients. The VEP uses data-driven, personalized virtual brain models derived from patient-specific anatomical (such as T1-MRI, DW-MRI, and CT scan) and functional data (such as stereo-EEG). It employs Markov Chain Monte Carlo (MCMC) and optimization methods from Bayesian inference to estimate a patients EZN while considering robustness, convergence, sensor sensitivity, and identifiability diagnostics. We describe both high-resolution neural field simulations and a low-resolution neural mass model inversion. The VEP workflow was evaluated retrospectively with 53 epilepsy patients and is now being used in an ongoing clinical trial (EPINOV).

labels: neurology


sentences:
Graph Theoretical Measures of Fast Ripples Support the Epileptic Network Hypothesis. The epileptic network hypothesis and epileptogenic zone (EZ) hypothesis are two theories of ictogenesis. The network hypothesis posits that coordinated activity among interconnected nodes produces seizures. The EZ hypothesis posits that distinct regions are necessary and sufficient for seizure generation. High-frequency oscillations (HFOs), and particularly fast ripples (FR), are thought to be biomarkers of the EZ. We sought to test these theories by comparing HFO rates and networks in surgical responders and non-responders, with no appreciable change in seizure frequency or severity, within a retrospective cohort of 48 patients implanted with stereo-EEG electrodes. We recorded inter-ictal activity during non-rapid eye movement sleep and semi- automatically detected and quantified HFOs. Each electrode contact was localized in normalized coordinates. We found that the accuracy of seizure-onset zone (SOZ) electrode contact classification using HFO rates (ripples 80-250 Hz, and FR 250-600 Hz) was not significantly different in surgical responders and non-responders, suggesting that in non-responders the EZ partially encompassed the SOZ(s) (p>0.05). We also found that in the responders, FR on oscillations exhibited a higher spectral content in the SOZ compared to the non-SOZ (p<1e-5). In contrast, in the non-responders the FR had a lower spectral content in the SOZ (p<1e-5). We constructed two different networks of FR with a spectral content > 350 Hz. The first was a rate- distance network that multiplied the Euclidian distance between FR generating contacts by the average rate of FR in the two contacts. The radius of the rate-distance network, which excluded SOZ nodes, discriminated non-responders, including patients not offered resection or responsive neurostimulation (RNS) due to diffuse multi-focal onsets, with an accuracy of 0.77 [95% confidence interval (CI) 0.56-0.98]. The second FR network was constructed using the mutual information (MI) between the timing of the events to measure functional connectivity. For most non-responders, this network had a longer characteristic path length, lower mean local efficiency in the non-SOZ, and a higher nodal strength among non-SOZ nodes relative to SOZ nodes. The graphical theoretical measures from the rate-distance and MI networks of 22 non-RNS treated patients was used to train a support vector machine, which when tested on 13 distinct patients classified non-responders with an accuracy of 0.92 [95% CI 0.75-1]. These results support the epileptic network hypothesis, refute the EZ hypothesis, and suggest that surgical non-responders, and patients not selected for resection or RNS, exhibit a decentralized FR network consisting of widely distributed, hyperexcitable FR generating nodes.

Abbreviated SummaryWeiss et al., report that fast ripples form a correlational network. In poor epilepsy surgery candidates, and patients that dont respond to surgery, the networks are widespread, highly active, and decentralized. This can be used to plan effective surgeries and supports the theory that seizures require a coordinated epileptic network.

Graphical abstract

O_FIG O_LINKSMALLFIG WIDTH=190 HEIGHT=200 SRC="FIGDIR/small/22269492v1_ufig1.gif" ALT="Figure 1">
View larger version (40K):
org.highwire.dtl.DTLVardef@101dc95org.highwire.dtl.DTLVardef@138eaedorg.highwire.dtl.DTLVardef@1c7a8b4org.highwire.dtl.DTLVardef@114d0b2_HPS_FORMAT_FIGEXP  M_FIG C_FIG


sentences: Single-nuclei paired multiomic analysis of young, aged, and Parkinson's disease human midbrain reveals age-associated glial changes and their contribution to Parkinson's disease Age is the primary risk factor for Parkinsons disease (PD), but how aging changes the expression and regulatory landscape of the brain remains unclear. Here, we present a single-nuclei multiomic study profiling shared gene expression and chromatin accessibility of young, aged and PD post-mortem midbrain samples. Combined multiomic analysis of midbrain nuclei along a pseudopathogenesis trajectory reveals all glial cell types are affected by age, but microglia and oligodendrocytes are further altered in PD. We present evidence for a novel age-associated oligodendrocyte subtype that appears during normal aging, characterized by elevated protein folding and chaperone-mediated autophagy pathways. Differential gene and protein-protein interaction analyses show that these functions are significantly compromised in PD. Peak-gene association from our paired data identifies differential cis-elements linked to regulation of differentially expressed genes between PD patients and neurologically healthy controls. Our study suggests a previously undescribed role for oligodendrocytes in aging and PD pathogenesis.


sentences:
The relationship between work disability and subsequent suicide or self-harm: A systematic scoping review. BackgroundWork disability occurs when an injury, illness or other health condition limits the ability of a worker to participate in paid employment. Several lines of evidence suggest that people with work disability are also at increased risk of suicide and intentional self-harm, however the evidence on this relationship has not previously been the subject of systematic review.

ObjectiveThis systematic scoping review aims to assess and summarise the research literature regarding the relationship between work disability and subsequent suicide or intentional self-harm.

MethodsPeer-reviewed quantitative and qualitative studies published in English from 1st January 2000 were included if they reported suicide or self-harm outcomes in people aged 15 years or older with work disability. Narrative synthesis summarised findings according to the system of work disability income support.

ResultsLiterature search yielded 859 records of which 47 eligible studies were included, including nine set in workers compensation, 20 in sickness absence, 13 in disability pension systems, and five from mixed cohorts. Of 44 quantitative studies, 41 reported a positive relationship between work disability and suicidal behaviour. The relationship is observed consistently across nations, work disability income support systems and in people with a range of health conditions. Several factors elevate risk of suicidal behaviour, including presence of mental health conditions and longer work disability duration. There were few quality studies in some nations and no suicide prevention interventions.

ConclusionThe risk of suicide and intentional self-harm is elevated in people experiencing work disability. While further observational research is required to fill evidence gaps, this review suggests the need for governments, employers and those involved in the delivery of care and support to people with work disability to focus on identification and monitoring of those at greatest risk of suicidal behaviour, as well as suicide prevention.

labels: occupational and environmental health


sentences:
Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank ObjectivesTo assess how accurately a genetic risk score (GRS) can identify incident prostate cancer in men seeing their general practitioner with lower urinary tract symptoms.

DesignCohort study.

SettingUK Biobank data linked to primary care records.

ParticipantsMen registered with the UK Biobank, eligible for the primary care data linkage, with a record showing that they consulted their general practitioner with lower urinary tract symptoms (LUTS) that could indicate possible undiagnosed prostate cancer.

Main outcome measuresA diagnosis of prostate cancer within two years of the patients first consultation with their general practitioner for LUTS.

ResultsA GRS is associated with prostate cancer in men with symptoms (OR=2.54 [2.16 to 2.99] p=5e-29). An integrated risk model including age and GRS applied to symptomatic men predicted prostate cancer with an AUC of 0.768 (0.739 to 0.796). Men aged 40 years and under in the bottom four GRS quintiles, aged 50 years and under in the bottom two GRS quintiles, and aged 50 to 60 years in the bottom GRS quintile had a two-year prostate cancer incidence below 1%, despite the presence of symptoms. The negative predictive value of the combined model exceeded 99%.

ConclusionsThis study is the first to apply a genetic risk score in a clinical setting to improve the triage of men with symptoms of prostate cancer. It demonstrates the added benefit of incorporating an estimate of genetic risk of prostate cancer into the clinical assessment of symptomatic men in primary care. Assessment of prostate cancer risk in men with LUTS is currently based on presenting clinical features alone. Men with the lowest genetic risk of developing prostate cancer could safely avoid invasive investigation, with adequate safety netting, whilst those identified with the greatest risk could be fast-tracked for further investigation.

labels: oncology


sentences:
The quality of vital signs measurements in electronic medical records varies by hospital, specialty, and patient demographics ObjectiveTo assess the frequency of digit preference in recording of vital signs in electronic healthcare records (EHRs) and associated patient and hospital factors.

Study Design and SettingWe used EHR data from Oxford University Hospitals, UK, between 01-January-2016 and 30-June-2019 and multivariable logistic regression to investigate associations between temperature readings of 36.0{degrees}C or systolic and diastolic blood pressure (SBP/DBP) readings both ending in zero and patient age, sex, ethnicity, deprivation, comorbidities, calendar time, hour of day, days into admission, hospital, day of week and speciality.

ResultsIn 4,305,914 records from 143,352 patients, there was an excess of temperature readings of 36.0{degrees}C (15.1%, 649,976/4,305,914), compared to an expected 4.9% from the underlying distribution. 2.2% (95,215) BP readings had a SBP and DBP both ending in zero vs. 1% expected by chance. Digit preference was more common in older and male patients, as length of stay increased, following a previous normal set of vital signs and typically more common in medical vs. surgical specialities. Differences were seen between hospitals, however, digit preference reduced over calendar time.

ConclusionVital signs may not always be accurately documented. Allowances and adjustments may be needed in observational analyses using these factors as outcomes or exposures.

Whats New?O_ST_ABSKey findingsC_ST_ABS{blacksquare} Digit preference in the recording of vital signs in electronic healthcare records is common, affecting approximately 10% of temperature measurements and 1% of blood pressure recordings in a large UK teaching hospital group
{blacksquare}These findings were obtained in hospitals using a semi-automated data capture system that required manual re-entry of vital signs into a tablet computer prior to automated upload to electronic patient records
{blacksquare}Digit preference was associated with patient characteristics and was more common in older and male patients, as length of stay increased and following previously normal vital signs
{blacksquare}Digit preference varied between hospitals, but decreased over time
{blacksquare}Digit preference was generally more common in medical compared to surgical specialties

What this adds to what is known{blacksquare} Most previous studies of data quality in electronic patient records have focused on the accuracy of coding
{blacksquare}This study focuses on the accuracy of numeric values in patient records, and also adds new data on patient and hospital factors associated with the accuracy of values in electronic patient records

Implications{blacksquare} Clinicians and researchers need to be aware that vital signs may not always be accurately documented
{blacksquare}Appropriate allowances and adjustments for digit preference should be considered in observational analyses using these factors as outcomes or exposures.
{blacksquare}Further work is required to understand the mechanisms behind values preference on a systems, patient and clinician level

labels: health informatics


sentences:
Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence Background and aimsSummarised in polygenic risk scores (PRS), the effect of common, low penetrant genetic variants associated with colorectal cancer (CRC), can be used for risk stratification.

MethodsTo assess the combined impact of the PRS and other main factors on CRC risk, 163,516 individuals from the UK Biobank were stratified as follows: 1. carriers status for germline pathogenic variants (PV) in CRC susceptibility genes (APC, MLH1, MSH2, MSH6, PMS2), 2. low (<20%), intermediate (20-80%), or high PRS (>80%), and 3. family history (FH) of CRC. Multivariable logistic regression and Cox proportional hazards models were applied to compare odds ratios (OR) and to compute the lifetime incidence, respectively.

ResultsDepending on the PRS, the CRC lifetime incidence for non-carriers ranges between 6% and 22%, compared to 40% and 74% for carriers. A suspicious FH is associated with a further increase of the cumulative incidence reaching 26% for non-carriers and 98% for carriers. In non-carriers without FH, but high PRS, the CRC risk is doubled, whereas a low PRS even in the context of a FH results in a decreased risk. The full model including PRS, carrier status, and FH improved the area under the curve (AUC) in risk prediction (0.704).

ConclusionThe findings demonstrate that CRC risks are strongly influenced by the PRS for both a sporadic and monogenic background. FH, PV, and common variants complementary contribute to CRC risk. The implementation of PRS in routine care will likely improve personalized risk stratification, which will in turn guide tailored preventive surveillance strategies in high, intermediate, and low risk groups.


sentences:
Effect of removing race correction factor in glomerular filtration rate estimation on predicting acute kidney injury after percutaneous coronary intervention BackgroundRace is a social and not a biological construct. Major societies have recommended removing a race correction factor when estimating glomerular filtration rate (eGFR). eGFR is a strong predictor for acute kidney injury (AKI) after percutaneous coronary intervention (PCI). We assessed the effect of removal of the race correction factor in eGFR calculation on the predictive ability of contemporary models for AKI after PCI.

MethodsWe used data from the American College of Cardiologys National Cardiovascular Data Registry (NCDR) CathPCI registry to assess the effect of removing a race correction in eGFR calculation on two previously published AKI models developed using NCDR data - a logistic regression-based model and a gradient boosting machine learning (ML) model. We first assessed the calibration and discrimination of these models with and without race correction and subsequently included race as an independent predictor in a model without race-corrected eGFR. We assessed model performance overall, and stratified by Black and non-Black subgroups. The models were trained on the same cohort used to develop the NCDR models and validated with a contemporaneous validation data set.

ResultsWe included 947,091 PCI procedures in 915,223 patients (mean age 64.8 years; 7.9% were Black and 32.8% women) with an AKI rate of 7.4%. In the NCDR model, inclusion of race correction in eGFR significantly underestimated AKI risk among Black patients (predicted 7.6% vs observed 10.2%) while slightly overestimating risk among non-Black patients (predicted 7.4% vs observed 7.1%). Removing the race correction partially corrected the underestimation among Black patients (predicted 8.2%). Including race as an independent predictor and introducing interaction terms further reduced the underestimation (predicted 10.1%). The receiver-operating-characteristic curve (AUC) was similar among these models, but was consistently lower in Black patients. Compared with the logistic model, the ML model had better calibration in Black patients (with race correction predicted 8.6% and without 8.7%) but still underestimated AKI risk. With race included as a predictor, the ML model achieved similarly good calibration in Black patients (predicted 10.1%). The AUCs of ML models were better than the logistic models but did not differ based on the inclusion of the race correction.

ConclusionRemoving the race correction in eGFR calculation has a positive effect of reducing the underestimation of the risk of AKI following PCI for Black patients. However, despite the reduction in underestimation, Black patients remain at elevated risk for AKI compared to non-Black patients. There is a need to better capture the determinants of this higher AKI risk through richer data and advanced modeling techniques.

labels: health systems and quality improvement


sentences:
Quantifying the direct and indirect protection provided by insecticide treated bed nets against malaria Long lasting insecticide treated mosquito nets (LLINs) provide both direct and indirect protection against bites from mosquitoes potentially transmitting malaria. Direct personal protection is provided to net users given both the nets physical barrier and its insecticidal action. Indirect mass protection for the community is afforded through reduced infectious bites per person annually (entomological inoculation rate, EIR). Quantifying these protective effects can help strategize options for net interventions, particularly as insecticide-resistant mosquitoes spread.

These types of protection are inherently linked, rendering it impossible to empirically quantify the contribution of each to the overall  community effect, instead we investigate this with a modelling framework and compare model predictions to trends with Demographic Health Survey (DHS) data.

Our modelling exercise predicts that in a situation with an EIR of 100, the reduction in EIR from an untreated net used by 80% of the population is 52% [95% CI: 12% - 84%] for users and 21% [95% CI: 0% - 57%] for non-users. Due to the impact of the insecticide, the reduction in EIR for LLINs is 89% [95% CI: 67% - 98%] for users and 74% [95% CI: 48% - 92%] for non-users, but this protection reduces as insecticide resistance in mosquitoes increases. Modelled trends in the difference in protection between users and non-users across endemicity and net usage levels are consistent with DHS data (2000-2018).

This study supports the concept of a community effect from LLINs, highlights the value of blocking and killing mosquitoes for community protection. Achieving high LLIN usage is always preferential, but there remains protection to non-users as the number of people using nets increases.

labels: infectious diseases


sentences:
Extreme γ' fibrinogen levels in COVID-19 patients BackgroundCOVID-19 progression can be accompanied by a "cytokine storm" that leads to secondary sequelae such as thrombosis and acute respiratory distress syndrome. Several inflammatory cytokines have been associated with COVID-19 progression, but have far too much daily intra-individual variability to be useful in tracking the course of the disease. In contrast, we have shown that the inflammatory biomarker {gamma} fibrinogen ({gamma} Fbg) has a 6-fold lower coefficient of variability compared to other inflammatory markers such as hs-CRP. Objectives: The aims of the study were to measure {gamma} Fbg in serial blood samples from COVID-19 patients at a tertiary care medical center in order to investigate its association with clinical measures of disease progression.

MethodsCOVID-19 patients at a tertiary care medical center were retrospectively enrolled between 3/16/2020 and 8/1/2020. {gamma} Fbg was measured using a commercial ELISA. Results: Our results showed that nine out of the seventeen patients with COVID-19 had extremely high levels of {gamma} Fbg. {gamma} Fbg levels were significantly associated with the need for ECMO and with mortality.

ConclusionsWe found that COVID-19 patients can develop extraordinarily high levels of {gamma} Fbg. The previous highest {gamma} Fbg level that we are aware of was 80.3 mg/dL found in a study of 10,601 participants in the ARIC study. These results have several important clinical implications. {gamma} Fbg contains a high affinity binding site for thrombin that binds to anion-binding exosite II on thrombin and protects it from inactivation by heparin. High levels of {gamma} Fbg therefore provide a reservoir of heparin-resistant clot-bound thrombin when the {gamma} Fbg is clotted. These findings have potential implications regarding prophylactic anticoagulation of COVID-19 patients and suggest that heparin prophylaxis may be less effective than using other anticoagulants, particularly direct thrombin inhibitors.


sentences: Molecular diagnosis of SARS-CoV-2: a validation of saliva samples Nasopharyngeal swabs are the most used in sample collecting for covid-19 tests in SARS-CoV-2 molecular diagnosis. However, this sampling method presents some disadvantages, since, in addition to being dependent on imported materials, it is invasive, causes discomfort in patients, and, presents the risk of contamination for the medical collection team. This study aimed at validating saliva samples to obtain viral RNA to be used in the molecular diagnostic test for SARS-CoV-2 using the RT-qPCR technique. Results presented 93,44% concordance in in comparison to nasopharyngeal swabs sampling. Therefore, saliva samples used in SARS-CoV-2 RT-qPCR detection tests presented consistent results.


sentences: Human Parainfluenza 2 & 4: clinical and genetic epidemiology in the UK, 2013-2017, reveals distinct disease features and co-circulating genomic subtypes Human Parainfluenza viruses (HPIV) are constituted by four members of the genetically distinct genera of Respirovirus (type 1 and 3) and Orthorubulavirus (type 2 and 4), causing significant upper and lower respiratory tract infections in both children and adults worldwide. However, despite frequent molecular diagnosis, they are frequently considered collectively or with HPIV4 overlooked entirely. We therefore investigated clinical and viral epidemiological distinctions of the relatively less prevalent Orthorubulaviruses HPIV2 & 4 at a regional UK hospital across four winter epidemic seasons. HPIV2 & 4 infection was observed across all age groups, but predominantly in children under 9 and adults over 40, with almost twice as many HPIV4 as HPIV2 cases. Fever, abnormal haematology, elevated C-reactive protein and hospital admission were more frequently seen in HPIV2 than HPIV4 infection. Each of the four seasonal peaks of either HPIV2, HPIV4 or both, closely matched that of RSV, occurring in November and December and preceding that of Influenza A. A subset of viruses were partially sequenced, indicating co-circulation of multiple subtypes of both HPIV2 & 4, but with little variation between each epidemic season or from limited global reference sequences.


sentences:
"I feel like my body is broken": Exploring the experiences of people living with long COVID BackgroundLong COVID, an illness affecting a subset of individuals after COVID-19, is distressing and poorly understood. Exploring the experiences of people with long COVID could help inform current conceptualizations of the illness, guide supportive care strategies, and validate patients perspectives on the condition. Thus, the objective of this study was to better understand and explore individuals experiences with long COVID and commonly reported symptoms, using qualitative data collected from open-ended survey responses.

MethodsData were collected from adults living with long COVID following a confirmed or suspected SARS-CoV-2 infection who participated in a larger observational, online survey. Within the larger survey, participants had the option of answering seven open-ended items. Data from the open-ended items were analyzed following guidelines for reflective thematic analysis.

ResultsFrom the 213 who were included in the online survey, 169 participants who primarily self-identified as women (88.2%), aged 40-49 (33.1%), and who had been experiencing long COVID symptoms for [≥] 6 months (58.6%) responded to the open-ended questions. Four overlapping and interconnected themes were identified: (1) My long COVID symptoms are numerous, hard to describe, and debilitating, (2) All aspects of my day-to-day functioning have been impacted, (3) I can no longer be physically active, and (4) I keep asking for help, but no one is listening, and very little is working.

ConclusionFindings highlight the complex nature of long COVID and show the ways in which individuals affected by the illness are negatively impacted. Participants recounted struggling and altering their daily activities while managing relapsing-remitting symptoms, an uncertain prognosis, lost pre-COVID identities, and a healthcare system (that does not always offer guidance nor take them seriously). More support and recognition for the condition are needed to help this cohort navigate the process of adapting to long COVID.


sentences: Capturing intrahost recombination of SARS-CoV-2 during superinfection with Alpha and Epsilon variants in New York City Recombination is an evolutionary process by which many pathogens generate diversity and acquire novel functions. Although a common occurrence during coronavirus replication, recombination can only be detected when two genetically distinct viruses contemporaneously infect the same host. Here, we identify an instance of SARS-CoV-2 superinfection, whereby an individual was simultaneously infected with two distinct viral variants: Alpha (B.1.1.7) and Epsilon (B.1.429). This superinfection was first noted when an Alpha genome sequence failed to exhibit the classic S gene target failure behavior used to track this variant. Full genome sequencing from four independent extracts revealed that Alpha variant alleles comprised between 70-80% of the genomes, whereas the Epsilon variant alleles comprised between 20-30% of the sample. Further investigation revealed the presence of numerous recombinant haplotypes spanning the genome, specifically in the spike, nucleocapsid, and ORF 8 coding regions. These findings support the potential for recombination to reshape SARS-CoV-2 genetic diversity.


sentences: Antigenic determinants of SARS-CoV-2-specific CD4+ T cell lines reveals M protein-driven dysregulation of interferon signaling We generated CD4+ T cell lines (TCLs) reactive to either SARSCoV-2 spike (S) or membrane (M) proteins from unexposed naive T cells from six healthy donor volunteers to understand in fine detail whether the S and M structural proteins have intrinsic differences in driving antigen-specific CD4+ T cell responses. Having shown that each of the TCLs were antigen-specific and antigen-reactive, single cell mRNA analyses demonstrated that SARS-CoV-2 S and M proteins drive strikingly distinct molecular signatures. Whereas the S-specific responses are virtually indistinguishable from those responses induced by other viral antigens (e.g. CMV), the M protein-specific CD4+ TCLs have a transcriptomic signature that indicate a marked suppression of interferon signaling, characterized by a downregulation of the genes encoding ISG15, IFITM1, IFI6, MX1, STAT1, OAS1, IFI35, IFIT3 and IRF7 (a molecular signature which is not dissimilar to that found in severe COVID-19). Our study suggests a potential link between the antigen specificity of the SARS-CoV-2-reactive CD4+ T cells and the development of specific sets of adaptive immune responses. Moreover, the balance between T cells of significantly different specificities may be the key to understand how CD4+ T cell dysregulation can determine the clinical outcomes of COVID-19.


sentences:
BNT162b2 vaccine boosts neutralizing antibodies to ancestral SARS-CoV-2 & Omicron variant in adults who previously received two doses of inactivated vaccine BackgroundLimited data exist on antibody responses to mixed vaccination strategies involving inactivated COVID-19 vaccines, particularly in the context of emerging variants.

MethodsWe conducted an open label trial of a third vaccine dose of an mRNA vaccine (BNT162b2, Fosun Pharma/BioNTech) in adults aged [≥]30 years who had previously received two doses of inactivated COVID-19 vaccine. We collected blood samples before administering the third dose and 28 days later, and tested for antibodies to the ancestral virus using a binding assay (ELISA), a surrogate virus neutralization test (sVNT) and a live virus plaque reduction neutralization test (PRNT). We also tested for antibodies against the Omicron variant using live-virus PRNT.

ResultsIn 315 participants, a third dose of BNT162b2 substantially increased antibody titers on each assay. Mean ELISA levels increased from an optical density (OD) of 0.3 to 2.2 (p<0. 001), and mean sVNT levels increased from an inhibition of 17% to 96% (p<0.001). In a random subset of 20 participants, the geometric mean PRNT50 titers rose very substantially by at least 24 fold from Day 0 to Day 28 against the ancestral virus (p<0.001) and rose by at least 11 fold against the Omicron variant (p<0.001). In daily monitoring, post-vaccination reactions subsided within 7 days for over 99% of participants.

ConclusionsA third dose of COVID-19 vaccination with an mRNA vaccine substantially improved antibody levels against the ancestral virus and the Omicron variant with well-tolerated safety profile, in adults who had received two doses of inactivated vaccine 6 months earlier.

SummaryIn this open label trial of Chinese adults aged [≥]30 years who received two doses of inactivated COVID-19 vaccine 6 months earlier, third-dose mRNA vaccine substantially improved antibody levels against the ancestral virus and Omicron variant with well-tolerated safety profile.


sentences:
A booster dose of mRNA-based COVID-19 vaccines fosters the development of an immune response in immunosuppressed fragile patients. SARS-CoV-2 vaccination has proven effective in inducing an immune response in healthy individuals and is progressively allowing to overcome the pandemic. Recent evidence has shown that response to vaccination in some vulnerable patients may be diminished, and it has been proposed a booster dose. We tested the kinetic of development of serum antibodies to the SARS-CoV-2 Spike protein, their neutralizing capacity, the CD4 and CD8 IFN-{gamma} T cell response in 328 subjects, including 131 immunocompromised individuals (cancer, rheumatologic, and hemodialysis patients), 160 healthcare workers (HCW) and 37 subjects older than 75 yo, after vaccination with two or three doses of mRNA vaccines. We stratified the patients according to the type of treatment. We found that immunocompromised patients, depending on the type of treatment, poorly respond to SARS-CoV-2 mRNA vaccines. However, an additional booster dose of vaccine induced a good immune response in almost all of the patients except those receiving anti-CD20 antibody. Similarly to HCW, previously infected and vaccinated immunocompromised individuals demonstrate a stronger SARS-CoV-2 specific immune response than those who are vaccinated without prior infection.

Summary blurbImmunocompromised patients poorly respond to two doses of SARS-CoV-2 mRNA vaccines. However, an additional booster dose elicits a strong humoral and cellular immune response in these subjects.

labels: allergy and immunology


sentences:
Causal associations between body fat accumulation and COVID-19 severity: A Mendelian randomization study PurposeThe causal effects of body fat mass and body fat-free mass on coronavirus disease 2019 (COVID-19) severity remain unclear. Here, we used Mendelian randomization (MR) to evaluate the causal relationships between body fat-related traits and COVID-19 severity.

Material and MethodsWe identified single nucleotide polymorphisms associated with body mass index (BMI) and direct measures of body fat (i.e., body fat percentage, body fat mass, and body fat-free mass) in 461,460, 454,633, 454,137, and 454,850 individuals of European ancestry from the UK Biobank, respectively. We then performed two-sample MR to ascertain their effects on severe COVID-19 (cases: 4,792; controls: 1,054,664) from the COVID-19 Host Genetics Initiative.

ResultsWe found that an increase in BMI, body fat percentage, and body fat mass by one standard deviation were each associated with severe COVID-19 (odds ratio (OR)BMI = 1.49, 95%CI: 1.19-1.87, P = 5.57x10-4; ORbody fat percentage = 1.94, 95%CI: 1.41-2.67, P = 5.07x10-5; and ORbody fat mass = 1.61, 95%CI: 1.28-2.04, P = 5.51x10-5). Further, we evaluated independent causal effects of body fat mass and body fat-free mass using multivariable MR and revealed that only body fat mass was independently associated with severe COVID-19 (ORbody fat mass = 2.91, 95%CI: 1.71-4.96, P = 8.85x10-5 and ORbody fat-free mass = 1.02, 95%CI: 0.61-1.67, P = 0.945).

ConclusionsThis study demonstrates the causal effects of body fat accumulation on COVID-19 severity and indicates that the biological pathways influencing the relationship between COVID-19 and obesity are likely mediated through body fat mass.

labels: endocrinology


sentences: Temporal trends in legionellosis national notification data and the effect of COVID-19, Switzerland, 2000- 2020 The notification rate of legionellosis in Switzerland and other European countries has markedly increased over the last 20 years. Here, we investigated the Swiss notification data on legionellosis from 2000-2020 in regards of overall time trend, content and data quality. We further explored the impact of the COVID-19 pandemic on the reported case numbers using an interrupted time series approach. Between 2000 and 2020, 5,980 cases were included in our analysis. The annual crude notification rate for legionellosis cases increased from 1.1/100,000 population (CI: 0.9 - 1.4) in 2000 to 5.6/100,000 population (CI: 5.1 - 6.1) in 2020. In recent years, the summer peaks have been more pronounced and some shifted earlier in the year. The highest notification rate was recorded in 2018 with 6.7/100,000 population (CI: 6.2 - 7.3). The hospitalisation rate for notified cases remained high across all study years (89.9%), while the case fatality rate slightly decreased (from 7.7% to 3.6%). COVID-19 containment measures, such as travel restrictions and/or related behavioural changes, are associated with a temporary decline in cases of 35%. Overall, the quality of the notification data was good. Clinical data were more susceptible to interferences than data from laboratory reporting, which could be observed most clearly in the decline of clinical reports by 4.3 percentage points in 2020. As the case classification for Legionnaires disease includes pneumonia symptoms, this decline could lead to an underestimation of Legionnaires disease cases, yet the continuous reporting though the diagnostic laboratories suggested a robust surveillance system for legionellosis in Switzerland.


sentences:
Reevaluation of Seroprevalence using a Semi-quantitative Anti-spike IgG in Health Care workers at an Academic Medical Center in Boston, Massachusetts BackgroundAccurate measurement of antibodies is a necessary tool for assessing exposure to SARS-CoV-2 and facilitating understanding of the role of antibodies in immunity. Most assays are qualitative in nature and employ a threshold to determine presence of antibodies. Semi-quantitative assays are now available. Here we evaluate the semi-quantitative SARS-CoV-2 IgG II (anti-spike (S)) assay. We aim to reassess the seroprevalence using anti-S assay and subsequently compare it to the previously measured IgG (anti-nucleoprotein (N)) in health care workers at an academic medical center in Boston.

Methods1743 serum samples from HCWs at Boston Medical Center were analyzed for SARS-CoV-2 anti-S IgG and IgM using the Abbott SARS-CoV-2 IgG II and{square}Abbott AdviseDx{square}SARS-CoV-2 IgM assay, respectively. Precision, linearity, positive and negative concordance with prior RT-PCR test were evaluated for anti-S IgG. Seroprevalence and its association with demographics variables was also assessed.

ResultsLinearity and precision results were clinically acceptable. The positive and negative concordance for anti-S IgG with RT-PCR was 88.2% (95% CI: 79.4% - 94.2%) and 97.43% (95% CI: 95.2% - 98.8%), respectively. Overall, 126 (7.2%) of 1,743 participants were positive by anti-S IgG. Among the 1302 participants with no prior RT-PCR, 40 (3.1%) were positive for anti-S IgG antibody. The original agreement in this population with the qualitative, anti-N IgG assay was 70.6%. Upon optimizing the threshold from 1.4 to 0.49 S/CO of the anti-N IgG assay, the positive agreement of the assay increases to 84.7%.

ConclusionThe anti-S IgG assay demonstrated reproducible and reliable measurements. This study highlights the presence of asymptomatic transmission among individuals with no prior history of positive RT-PCR. It also highlights the need for optimizing thresholds of the qualitative SARS-CoV-2 IgG assay for better agreement between assays by the same vendor.


sentences: A high-throughput approach measures cell type-specific telomere lengths in fixed archival tissues from patient cohorts for research on prognosis Telomeres, the repetitive DNA elements at chromosome ends, are pivotal for maintenance of genome integrity. Previous studies from our group and others have highlighted the translational potential of tissue-based telomere length measurements to address the clinical challenge of improving diagnosis, individualized risk stratification, and accurate prognostication of different diseases. Here, we describe a high-throughput method that quantitates cell type-specific telomere lengths at a single cell level in archival tissues from patient cohorts for research on prognosis. This approach is based on telomere-specific fluorescence in situ hybridization (FISH) combined with multiplex immunostaining for cell type-specific antibodies, followed by semi-automated slide scanning and multi-channel acquisition of fluorescent images using the TissueFAXS Plus microscopy workstation and TissueQuest software (TissueGnostics). Here, we demonstrate that this method is sufficiently robust and reproducible to detect biologically significant differences in telomere lengths in archived tissues either on whole slides or sampled across tissue microarrays, which is essential when assessing prognosis in large patient cohorts.

labels: pathology


sentences: Associations between maternal iron supplementation in pregnancy and offspring growth and cardiometabolic risk outcomes in infancy and childhood It was previously observed that maternal iron supplementation in pregnancy was associated with increased offspring size and adiposity at birth, possibly mediated through increased risk of gestational diabetes. In this study we explored associations of maternal iron supplementation in pregnancy with postnatal offspring growth in infancy and indices of cardiometabolic disease risk factors such as glucose tolerance, insulin sensitivity and blood pressure in mid-childhood (at [~]9.5 years of age) in the Cambridge Baby Growth Study. In infancy adiposity-promoting associations with maternal iron supplementation in pregnancy were evident at 3 months of age (e.g. mean difference in skinfold thickness: {beta}=+0.15 mm, p=0.02, in n=341 whose mothers supplemented versus 222 that did not; waist circumference: {beta}=+0.7 cm, p=0.04, in n=159 and 78, respectively) but differences lessened after this time (e.g. 3-12 month change in mean difference in skinfold thickness: {beta}=-0.2 mm, p=0.03, in n=272 and 178, respectively). At [~]9.5 years of age associations with maternal iron supplementation in pregnancy were not evident for markers of growth, glucose tolerance, insulin sensitivity or secretion. However, children whose mothers supplemented with iron in pregnancy had lower mean arterial blood pressures ({beta}=-1.0 mmHg, p=0.03, in n=119 and 78, respectively). These results suggest that most of the associations of maternal iron supplementation in pregnancy on growth and adiposity evident at birth disappear during infancy, but there may be some evidence of long-term nutritional programming evident later in childhood.

labels: pediatrics


sentences:
Infection and transmission risks in schools and contribution to the COVID-19 pandemic in Germany - a retrospective observational study using nation-wide and regional health and education agency notification data IntroductionCurrently, information on infection and transmission risks of students and teachers in schools, the effect of infection control measures for schools as well as the contribution of schools to the overall population transmission of SARS-CoV-2 in Germany are limited to regional data sets restricted to short phases of the pandemic.

MethodsWe used German federal state (NUTS-2) and county (NUTS-3) data from national and regional public health and education agencies to assess infection risk and secondary attack rates (SARs) from March 2020 to October 2021 in Germany. We used multiple regression analysis and infection dynamic modelling, accounting for urbanity, socioeconomic factors, local population infection dynamics and age-specific underdetection to investigate the effects of infection control measures.

ResultsWe included (1) nation-wide NUTS-2 level data from calendar weeks (W) 46-50/2020 and W08-40/2021 with 304676 infections in students and 32992 in teachers; (2) NUTS-3 level data from W09-25/2021 with 85788 student and 9427 teacher infections and (3) detailed data from 5 regions covering W09/2020 to W27/2021 with 12814 infections, 43238 contacts and 4165 secondary cases for students (for teachers 14801, 5893 and 472 respectively).

In counties with mandatory surgical mask wearing during class in all schools infection risk of students and teachers was reduced by 56/100.000 persons per 14 days and by 30% and 24% relative to the population respectively. Overall contribution to population infections of contacts in school settings was 2-13%. It was lowest during school closures and vacation and highest during normal presence class intervals. Infection risk for students increased with age and was similar to or lower than the population risk during second and third waves in Germany and higher in summer 2021. Infection risk of teachers was higher than the population during the second wave and similar or lower thereafter with stricter measures in place. SARs for students and staff were below 5% in schools throughout the study period. SARs in households more than doubled from 14% W21-39/2020 to 29-33% in W08-23/2021. Most contacts were reported for schools, yet most secondary cases originated in households. In schools, staff predominantly infected staff and students predominantly infected students.

ConclusionOpen schools under hygiene measures and testing strategies contribute up to 13% of nation-wide infections in Germany and as little as 2% during vacations/school closures. Tighter infection control measures stabilised school SARs whilst household SARs more than doubled as more transmissible variants became prevalent in Germany. Mandatory mask wearing during class in all school types effectively reduces secondary transmission in schools, as do reduced attendance class models.

labels: public and global health


sentences: Using Survey Data to Estimate the Impact of the Omicron Variant on Vaccine Efficacy against COVID-19 Infection Data collected in the Global COVID-19 Trends and Impact Surveys (UMD Global CTIS), and data on variants sequencing from GISAID, are used to evaluate the impact of the Omicron variant (in South Africa and other countries) on the prevalence of COVID-19 among unvaccinated and vaccinated population, in general and discriminating by the number of doses. In South Africa, we observe that the prevalence of COVID-19 in December (with strong presence of Omicron) among the unvaccinated population is comparable to the prevalence during the previous wave (in August-September), in which Delta was the variant with the largest presence. However, among vaccinated, the prevalence of COVID-19 in December is much higher than in the previous wave. In fact, a significant reduction of the vaccine efficacy is observed from August-September to December. For instance, the efficacy drops from 0.81 to 0.30 for those vaccinated with 2 doses, and from 0.51 to 0.09 for those vaccinated with one dose. The study is then extended to other countries in which Omicron has been detected, comparing the situation in October (before Omicron) with that of December. While the reduction measured is smaller than in South Africa, we still found, for instance, an average drop in vaccine efficacy from 0.53 to 0.45 among those vaccinated with two doses. Moreover, we found a significant negative (Pearson) correlation of around -0.6 between the measured prevalence of Omicron and the vaccine efficacy.


sentences: Multiomic investigations of Body Mass Index reveal heterogeneous trajectories in response to a lifestyle intervention Multiomic profiling is useful in characterizing heterogeneity of both health and disease states. Obesity exerts profound metabolic perturbation in individuals and is a risk factor for multiple chronic diseases. Here, we report a global atlas of cross-sectional and longitudinal changes associated with Body Mass Index (BMI) across 1,100+ blood analytes, as well as their correspondence to host genome and fecal microbiome composition, from a cohort of 1,277 individuals enrolled in a wellness program. Machine learning-based models predicting BMI from blood multiomics captured heterogeneous states of both metabolic and gut microbiome health better than classically measured BMI, suggesting that multiomic data can provide deeper insight into host physiology. Moreover, longitudinal analyses identified variable trajectories of BMI in response to a lifestyle intervention, depending on the analyzed omics platform; metabolomics-based BMI decreased to a greater extent than actual BMI, while proteomics-based BMI exhibited greater resistance. Our analysis further elucidated blood analyte-analyte associations which were significantly modified by obesity and partially reversed in the metabolically obese population through the program. Altogether, our findings provide an atlas of the gradual blood perturbations accompanying obesity and serve as a valuable resource for robustly characterizing metabolic health and identifying actionable targets for obesity.


sentences:
Overdiagnosis and treatment of COPD in nonagenarians BackgroundThe prevalence of COPD is increasing with age. However, the effects of age-dependent decline in lung function on diagnosis and treatment of COPD in nonagenarians are uncertain.

ObjectivesTo determine performance of spirometry, prescription of COPD medications, and COPD-related acute care visits and hospitalizations in patients 90 years and older with physician-diagnosed COPD.

MethodsHealth records of 166 consecutive patients 90 years and older with physician-diagnosed COPD at a university-affiliated medical center in Chicago were reviewed. Pertinent demographic, clinical, and physiological data were extracted.

ResultsPatients were predominantly ex-smoker (96%), African American (52%) males (96%). Sixty patients (36%) had no spirometry testing on record. Of the remaining 106 patients, 11 (10%) had baseline FEV1/FVC[≥]0.70, 24 (23%) had post-bronchodilator FEV1/FVC [≥]0.70, 28 (26%) had FEV1/FVC <0.70 and [≥]LLN, and 43 (41%) had FEV1/FVC <0.70 and <LLN. Thus, only 71 of 166 patients 90 years and older (43%) fulfilled the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations. Nonetheless, COPD medications, predominantly short-acting {beta}2 agonists and long-acting muscarinic antagonists, were prescribed to 95 of the 166 patients (57%). No significant differences in prevalence of co-morbidities and prescribed COPD medications, including systemic corticosteroids and anti-infectives prescribed during unscheduled healthcare visits and hospitalizations, were found between the four groups.

ConclusionsThese data suggest that a large proportion of nonagenarians at our medical center are overdiagnosed with and treated for COPD. A larger, multi-center, prospective study is warranted to support or refute these retrospective observations.


sentences:
Effects of amyloid and APOE4 on medial temporal lobe subregions in cognitively unimpaired elderly Medial temporal lobe (MTL) sub-structures are differentially affected in early Alzheimers disease (AD), with a specific involvement of the entorhinal cortex (ERC), the perirhinal cortex (PRC) and CA1. However, the impact of amyloid (A{beta}) pathology and APOE {varepsilon}4 on MTL subregional atrophy remains relatively unknown. Our aim was to uncover these effects to further our understanding of the mechanisms underlying MTL atrophy in a population at-risk for AD.

We used baseline data from 130 unimpaired older adults (mean age: 68.9 {+/-} 3.8 years) from the Age-Well randomized controlled trial for whom high-resolution structural MRI (T2-weighted; 0.4x0.4x2.5mm3), amyloid-PET (Florbetapir) and APOE genotype were available. Participants were dichotomized into amyloid positive (A{beta}+, n=27) and negative (A{beta}-, n=103), and APOE {varepsilon}4 carrier ({varepsilon}4+, n=35) and non-carriers ({varepsilon}4-, n=95). Hippocampal subfield (CA1, CA2, CA3, dentate gyrus [DG], subiculum [SUB]) and extra-hippocampal region (ERC, Brodmann area [BA] 35 and 36, and parahippocampal cortex [PHC]) volumes were estimated using ASHS and normalized by total intracranial volume. For each subregion, group comparisons were performed (A{beta}+ vs A{beta}- and {varepsilon}4+ vs {varepsilon}4-) using ANCOVAs, including age, sex and education as covariates. Interactions with age (i.e., A{beta} status * age and APOE {varepsilon}4 status * age) were also investigated for each subregion.

No significant differences were observed between A{beta}+ and A{beta}-, nor between {varepsilon}4+ and {varepsilon}4-. However, a significant A{beta} status * age interaction were observed for CA1 (p<0.05), where volumes were negatively associated with age in the A{beta}+ group only. In addition, significant APOE {varepsilon}4 status * age interactions were found for CA1, SUB, ERC, DG and the whole hippocampus (p<0.05), where volumes were negatively associated with age in the {varepsilon}4+ group only.

Overall, our analyses showed that both A{beta} and APOE {varepsilon}4 status interact with age on CA1, which is known to be specifically atrophied in early AD. In addition, APOE {varepsilon}4 status mediated the effects of age on other subregions (SUB, ERC, DG), suggesting a more important contribution of APOE {varepsilon}4 than amyloid to MTL atrophy in cognitively unimpaired population. These results are particularly important to develop MRI-based biomarkers to detect early AD and further our understanding of the mechanisms underlying MTL atrophy.


sentences:
Risk Factors for Delirium in Elderly Patients After Lumbar Spinal Fusion Background ContextPostoperative delirium is a clinically significant acute disorder of consciousness especially prevalent in older adult patients, of which more than 100,000 per year undergo spinal fusion surgery. There are no proven preventative therapies, and delirium is associated with increased postoperative complications, functional decline, morbidity, and mortality.

PurposeTo identify perioperative risk factors for postoperative delirium (POD) after lumbar spinal fusion procedures in patients aged 65 or older.

Study DesignRetrospective Review

Patient Sample702 patients who underwent lumbar spinal fusion surgery from 11/13/2017 to 1/30/2021.

Outcome MeasuresThe primary outcome was the presence of postoperative delirium assessed by the Delirium Observation Screening Scale (DOSS) and Confusion Assessment Method for the ICU (CAM-ICU).

MethodsDemographic, surgical, and perioperative data were obtained from the electronic medical records. The primary outcome was presence of postoperative delirium. Univariate and multivariate analyses were performed. A binomial logistic regression model was designed using a custom written MATLAB script.

ResultsOf the 702 patients included in the study, 173 (24.6%) developed POD. Our analysis revealed that older age (p < 0.001), lower preoperative hemoglobin (p < 0.001), and higher ASA grade (p < 0.001), were significant preoperative risk factors for developing POD. The only significant intraoperative risk factor was a higher number of spinal levels that were instrumented (p < 0.001). Higher pain scores on postoperative day 1 (p < 0.001), and lower postoperative hemoglobin (p < 0.001) were associated with increased POD; as were ICU admission (p < 0.001) and increased length of ICU stay (p < 0.001). Patients who developed POD had a longer hospital stay (p < 0.001) with lower rates of discharge to home as opposed to an inpatient facility (p < 0.001).

ConclusionsRisk factors for older adults undergoing lumbar spinal fusion surgery include advanced age, lower preoperative and postoperative hemoglobin, higher ASA grade, greater extent of surgery, and higher postoperative pain scores. Patients with delirium had a higher incidence of postoperative ICU admission, increased length of stay, decreased likelihood of discharge to home and increased mortality, all consistent with prior studies. Further studies will determine whether adequate management of anemia and pain lead to a reduction in the incidence of postoperative delirium in these patients.

labels: orthopedics


sentences:
Investigating causal relations between sleep duration and risks of adverse pregnancy and perinatal outcomes: Linear and nonlinear Mendelian randomization analyses in up to 356,069 European women BackgroundObservational studies have reported maternal short/long sleep duration to be associated with adverse pregnancy and perinatal outcomes. However, it remains unclear whether there are nonlinear causal effects. Our aim was to use multivariable regression (MVreg) and Mendelian randomization (MR) to examine nonlinear effects of sleep duration on stillbirth, miscarriage, gestational diabetes, hypertensive disorders of pregnancy, perinatal depression, preterm birth, low/high offspring birthweight (LBW/HBW).

MethodsWe used data from European women in UK Biobank (UKB, N=208,140), FinnGen (N=[~]123,579), Avon Longitudinal Study of Parents and Children (N=6826), Born in Bradford (N=2940) and Norwegian Mother, Father and Child Cohort Study (MoBa, N=14,584). We used 78 previously identified genetic variants as instruments for sleep duration, and investigated its effectsusing two-sample MR and one-sample nonlinear MR (in UKB only). We compared MR findings with MVreg in MoBa (N=76,669), where maternal sleep duration was measured at 30 weeks.

ResultsIn UKB, MR provided evidence of nonlinear effects of sleep duration on stillbirth, perinatal depression and LBW, but not for other outcomes. Shorter and longer duration increased stillbirth and LBW; shorter duration increased perinatal depression. For example, there was a lower risk of LBW with increasing duration (odds ratio 0.79 per one-hour/day (95% confidence interval (CI): 0.68, 0.93) in the shortest duration group and a higher risk (odds ratio 1.38 (95% CI: 1.06, 1.81) in the longest duration group, suggesting shorter and longer duration increased the risk. These were supported by the lack of evidence of a linear effect of sleep duration with any outcome using two-sample MR. In MVreg, risks of all outcomes (except for stillbirth showing opposite directions) were higher in the women reporting <5- and [≥]10-hours/day sleep compared with the reference category of 8-9-hours/day, despite some wide CIs including the null. Nonlinear models fitted the data better than linear models for most outcomes(likelihood ratio P-value=0.02 to 3.2x10-52), except for stillbirth and gestational diabetes.

ConclusionsOur results supported possible nonlinear sleep duration effects on perinatal depression and LBW. Statistical support for nonlinear models across outcomes suggests potential nonlinear effects on other outcomes that larger studies could detect.

labels: epidemiology


sentences:
Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassay BackgroundAntibodies induced by COVID-19 vaccination have been shown to wane over time. Current tests for assessing virus-neutralizing antibodies are complex and time-intensive. There is a need for a simple diagnostic test that measures levels of protective antibodies to help monitor immunity status.

MethodUsing a commercially available FDA-authorized semi-quantitative SARS-CoV-2 IgG test, we monitored the duration of the immune response in dried blood microsamples (DBS) and saliva to vaccination by 3 different vaccines across prospective cohorts of 8 COVID-19 naive and 29 COVID-19 recovered individuals over a six-month period. We correlated the results to a binding blockade assay validated to a live virus neutralization assay to validate the test for measurement of protective antibodies.

ResultsThe immune response characteristics between the two mRNA vaccines were similar over the 6-month period in both the COVID-19 naive and recovered cohorts. IgG titers in DBS were generally 3-4 orders of magnitude higher than in saliva, and longitudinal profiles were highly correlated between the two matrices (Rm = 0.80). Median IgG concentrations post-vaccination declined to <10% neutralization capacity with all vaccines by six months.

ConclusionsThe potential of a simple, fully automated high throughput anti-SARS-CoV-2 IgG test to quantitatively measure protective antibodies in samples collected remotely or at the point of care was demonstrated. The IgG immune response and protective immunity was shown to decline significantly by six months.

Plain Language SummaryIn response to infection the immune system produces proteins called antibodies that recognize and bind to foreign invaders. Vaccines train the immune system to recognize and produce antibodies against specific invaders, such as SAR-CoV-2. Measurement of antibody levels in blood help monitor a persons response to vaccination and have been shown to correlate with protection against disease, which wanes over time following vaccination. It is desirable to have an easy test that predicts protection against infection and measuring antibody levels may provide a solution, however different tests report results differently hindering the establishment of a cutoff for protected vs. not. We quantified antibody levels in saliva and dried blood microsamples (DBS) following vaccination using an automated semi-quantitative IgG test. By reporting concentration of antibodies, and if anchored to an international standard, this test could help establish a cutoff of protection that would be transferable across the multiple different test types. Furthermore, by measuring in saliva and DBS we demonstrate an easy path to at-home or point-of-care sample collection, which could allow wide-scale monitoring of immune protection against SARS-CoV-2.


sentences:
Prior health-related behaviours in children (2014-2020) and association with a positive SARS-CoV-2 test during adolescence (2020-2021): a retrospective cohort study using survey data linked with routine health data in Wales, UK ObjectivesExamine if pre-COVID-19 pandemic (prior March 2020) health-related behaviours during primary school are associated with i) being tested for SARS-CoV-2 and ii) testing positive between 1 March 2020 to 31 August 2021.

DesignRetrospective cohort study using an online cohort survey (January 2018 to February 2020) linked to routine PCR SARS-CoV-2 test results.

SettingChildren attending primary schools in Wales (2018-2020), UK who were part of the HAPPEN school network.

ParticipantsComplete linked records of eligible participants were obtained for n=7,062 individuals. 39.1% (n=2,764) were tested (age 10.6{+/-}0.9, 48.9% girls) and 8.1% (n=569) tested positive for SARS-CoV-2 (age 10.6{+/-}1.0, 54.5% girls).

Main outcome measuresLogistic regression of health-related behaviours and demographics were used to determine Odds Ratios (OR) of factors associated with i) being tested for SARS-CoV-2 and ii) testing positive for SARS-CoV-2.

ResultsConsuming sugary snacks (1-2 days/week OR=1.24, 95% CI 1.04 - 1.49; 5-6 days/week 1.31, 1.07 - 1.61; reference 0 days) can swim 25m (1.21, 1.06 - 1.39) and age (1.25, 1.16 - 1.35) were associated with an increased likelihood of being tested for SARS-CoV-2. Eating breakfast (1.52, 1.01 - 2.27), weekly physical activity [≥] 60 mins (1-2 days 1.69, 1.04 - 2.74; 3-4 days 1.76, 1.10 - 2.82, reference 0 days), out of school club participation (1.06, 1.02 - 1.10), can ride a bike (1.39, 1.00 - 1.93), age (1.16, 1.05 - 1.28) and girls (1.21, 1.00 - 1.46) were associated with an increased likelihood of testing positive for SARS-CoV-2. Living in least deprived quintiles 4 (0.64, 0.46 - 0.90) and 5 (0.64, 0.46 - 0.89) compared to the most deprived quintile was associated with a decreased likelihood.

ConclusionsAssociations may be related to parental health literacy and monitoring behaviours. Physically active behaviours may include co-participation with others, and exposure to SARS-CoV-2. A risk versus benefit approach must be considered given the importance of health-related behaviours for development.

STRENGTHS AND LIMITATIONSO_LIInvestigation of the association of pre-pandemic child health-related behaviour measures with subsequent SARS-CoV-2 testing and infection.
C_LIO_LIReporting of multiple child health behaviours linked at an individual-level to routine records of SARS-CoV-2 testing data through the SAIL Databank.
C_LIO_LIChild-reported health behaviours were measured before the COVID-19 pandemic (1 January 2018 to 28 February 2020) which may not reflect behaviours during COVID-19.
C_LIO_LIHealth behaviours captured through the national-scale HAPPEN survey represent children attending schools that engaged with the HAPPEN Wales primary school network and may not be representative of the whole population of Wales.
C_LIO_LIThe period of study for PCR-testing for and testing positive for SARS-CoV-2 includes a time frame with varying prevalence rates, approaches to testing children (targeted and mass testing) and restrictions which were not measured in this study.
C_LI


sentences:
Remdesivir for the Treatment of COVID-19: An Updated Systematic Review and Meta-Analysis BackgroundThe benefits of remdesivir in the treatment of hospitalized patients with Covid-19 remain debated with the National Institutes of Health and the World Health Organization providing contradictory recommendations for and against use.

MethodsWe performed a systematic review of randomized controlled trials (RCTs) of remdesivir for the treatment of hospitalized patients with COVID-19. The primary outcome was mortality, stratified by oxygen use (none, supplemental oxygen without mechanical ventilation, and mechanical ventilation). We conducted a frequentist random effects meta-analysis on the risk ratio (RR) scale and, to better contextualize the probabilistic benefits, we also performed a bayesian random effects meta-analysis on the risk difference scale.

ResultsWe identified 8 randomized trials, totaling 9157 participants. The RR for mortality comparing remdesivir versus control was 0.71 (95% confidence interval [CI] 0.42-1.22; I2=0.0%) in the patients who did not require supplemental oxygen; 0.83 (95%CI 0.73-0.95; I2=0.0%) for nonventilated patients requiring oxygen; and 1.19 (95%CI 0.98-1.44 I2=0.0%) in the setting of mechanical ventilation. Using neutral priors, the probabilities that remdesivir reduces mortality were 74.7%, 96.9% and 8.9%, respectively. The probability that remdesivir reduced mortality by more than 1% was 88.1% for nonventilated patients requiring oxygen.

ConclusionBased on this meta-analysis, there is a high probability that remdesivir reduces mortality for nonventilated patients with COVID-19 requiring supplemental oxygen therapy.


sentences:
Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients BackgroundThe use of rapid antigen diagnostics tests (Ag-RDT) has gained widespread acceptance as an alternative method for diagnosis of COVID-19 outside of health care settings. Various authors have reported that saliva is a reliable specimen, alternative to nasopharyngeal and mid-nasal swabs, to detect SARS-CoV-2 infections by RT-PCR. We assessed the performance of buccal swabs containing saliva for SARS-CoV-2 detection by Ag-RDT, using mid-nasal specimens as a reference in the northern area of Barcelona (Catalonia, Spain)

MethodsIn the context of routine clinical diagnosis of mild COVID-19 patients, we enrolled 300 adults in a study to directly compare mid-nasal swabs and saliva specimens for SARS-CoV-2 detection by Ag-RDT.. When mid-nasal and buccal Ag-RDTs showed discordant results, a third mid-nasal swab was collected and analysed by RT-PCR.

ResultsPaired samples were successfully obtained in 300 suspected cases of SARS-CoV-2 infection. Of the 300 paired samples, Ag-RDT with the mid-nasal swab detected 139 (46.3%) positive COVID-19 cases. In comparison, buccal swabs showed a sensitivity and specificity of 31.7% (44/139) and 98.8% (159/161), respectively. 65 discordant results with positive mid-nasal swabs and negative buccal swabs were tested by RT-qPCR. All samples tested by Rt-PCR resulted positive, with a mean cycle threshold (Ct) of 28.3 (SD 7.3).

ConclusionOur findings show that mid-nasal swabs have better performance than buccal swabs for detecting SARS-CoV-2 with Ag-RDT tests. Of note, the sensitivity of buccal samples was affected in samples with high viral loads (Ct<33), suggesting that buccal swabs might not be sensitive enough to detect individuals at risk of transmission. Taken together, the existing literature and the results provided in our analysis we advise against the use of buccal specimens for SARS-CoV-2 diagnostics with Ag-RDT.


sentences:
Severe outcomes in residents of Long Term Care Facilities following infection with SARS-CoV-2 Omicron variant (VIVALDI study) BackgroundRecently there has been a rapid, global increase in SARS-CoV-2 infections associated with the Omicron variant (B.1.1.529). Although severity of Omicron cases may be reduced, the scale of infection suggests hospital admissions and deaths may be substantial. Definitive conclusions about disease severity require evidence from populations with the greatest risk of severe outcomes, such as residents of Long-Term Care Facilities (LTCFs).

MethodsWe used a cohort study to compare the risk of hospital admission or death in LTCF residents in England who had tested positive for SARS-CoV-2 in the period shortly before Omicron emerged (Delta dominant) and the Omicron-dominant period, adjusting for age, sex, vaccine type, and booster vaccination. Variants were confirmed by sequencing or spike-gene status in a subset.

ResultsRisk of hospital admission was markedly lower in 1241 residents infected in the Omicron-period (4.01% hospitalised, 95% CI: 2.87-5.59) compared to 398 residents infected in the pre-Omicron period (10.8% hospitalised, 95% CI: 8.13-14.29, adjusted Hazard Ratio 0.50, 95% CI: 0.29-0.87, p=0.014); findings were similar in residents with confirmed variant. No residents with previous infection were hospitalised in either period. Mortality was lower in the Omicron versus the pre-Omicron period, (p<0.0001).

ConclusionsRisk of severe outcomes in LTCF residents with the SARS-CoV-2 Omicron variant was substantially lower than that seen for previous variants. This suggests the current wave of Omicron infections is unlikely to lead to a major surge in severe disease in LTCF populations with high levels of vaccine coverage and/or natural immunity.

Trial Registration NumberISRCTN 14447421


sentences:
B.1.617.2 SARS-CoV-2 (Delta) variant is associated with increased risk of hospitalization and death compared with B.1.1.7 SARS-CoV-2 (Alpha) variant IntroductionThe B.1.617.2 variant (Delta) was associated with increased transmissibility and lower vaccine effectiveness than the B.1.1.7 variant (Alpha). However, the effect of the B.1.617.2 variant on disease severity remains unclear. This study aims to assess whether infection with the B.1.617.2 variant was associated with a higher risk of serious illness, compared with other co-circulating variants, measured through hospitalization and death by COVID-19 in Portugal.

MethodsWe conducted a matched cohort study in adult individuals diagnosed with SARS-CoV-2/COVID-19 infection between March 29 and August 1, 2021. Cases were individuals with a positive PCR test notified to the surveillance system. SARS-CoV-2 variants were classified first by genomic sequencing (WGS) and, if this information was unavailable, by detecting the S gene target failure.

Delta (B.1.617.2) and Alpha (B.1.1.7) cases were matched on the week of diagnosis at a 1 to k ratio (k being the maximum number of unexposed available in that week) to maximize the inclusion of unexposed, using the nearest-neighbor algorithm. The hazard risk and 95% confidence intervals of hospitalization and death among those infected with the Delta (B.1.617.2) variant vs. Alpha (B.1.1.7) was estimated using a Cox proportional hazards model, adjusting for confounding for sex, age, and vaccination status.

ResultsA total of 2,778 cases were included in the study. Of the total, 1 742 (68%) were identified as B.1.617.2 variant cases and 3 629 (32%) as B.1.1.7 variant. Within the B.1.1.7 variant cases 106 (2.9%) were hospitalized, and 110 (6.3%) within the B.1.617.2 variant cases. A total of 29 deaths were reported, 8 (0.2%) in patients infected with B.1.1.7 variant and 21 (1.2%) in patients with the B.1.617.2 variant. The confounding adjusted risk of hospitalization, in persons infected with the B.1.617.2 variant was 2.44 (95%CI 1.85; 3.20) times higher than the risk of hospitalization among B.1.1.7 variant cases, and the confounding-adjusted risk of death for B.1.617.2 variant cases was 5.20 (95%CI 2.20; 12.29) times higher than the risk of death in patients infected by B.1.1.7 variant.

ConclusionThe B.1.617.2 variant is associated with an increased risk of hospitalization and death compared with the B.1.1.7 variant.


sentences:
Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2) IntroductionEarly reports showed that Omicron (BA.1) SARS-CoV-2 could be less severe. However, the magnitude of risk reduction of hospitalization and mortality of Omicron (BA.1) infections compared with Delta (B.1.617.2) is not yet clear. This study compares the risk of severe disease among patients infected with the Omicron (BA.1) variant with patients infected with Delta (B.1.617.2) variant in Portugal.

MethodsWe conducted a cohort study in individuals diagnosed with SARS-CoV-2 infection between 1st and 29th December 2021. Cases were individuals with a positive PCR test notified to the national surveillance system. SARS-CoV-2 variants were classified first by whole genomic sequencing (WGS) and, if this information was unavailable, by detecting the S gene target failure. We considered a hospitalization for all the patients admitted within the 14 days after the SARS-CoV-2 infection; after that period, they were censored.

The comparison of the risk of hospitalization between Omicron (BA.1) and Delta (B.1.617.2) VOC was estimated using a Cox proportional hazards model. The mean length of stay was compared using linear regression, and the risk of death between Omicron and Delta patients was estimated with a penalized logistic regression. All models were adjusted for sex, age, previous infection, and vaccination status.

ResultsWe included 15 978 participants aged 16 or more years old, 9 397 infected by Delta (B.1.617.2) and 6 581 infected with Omicron (BA.1). Within the Delta (B.1.617.2) group, 148 (1.6%) were hospitalized, and 16 (0.2%) were with the Omicron (BA.1). A total of 26 deaths were reported, all in participants with Delta (B.1.617.2) infection. Adjusted HR for hospitalization for the Omicron (BA.1) variant compared with Delta (B.1.617.2) was 0.25 (95%CI 0.15 to 0.43). The length of stay in hospital for Omicron (BA.1) patients was significantly shorter than for Delta (confounding-adjusted difference -4.0 days (95%CI -7.2 to -0.8). The odds of death were 0.14 (95% CI 0.0011 to 1.12), representing a reduction in the risk of death of 86% when infected with Omicron (BA.1) compared with Delta (B.1.617.2).

ConclusionOmicron (BA.1) was associated with a 75% risk reduction of hospitalization compared with Delta (B.1.617.2) and reduced length of hospital stay.


sentences:
Gaseous micro-embolism (GME) is associated with systemic inflammatory response syndrome (SIRS) after open heart surgery. A missing piece of a complex puzzle? BackgroundGaseous micro-embolism (GME) occurring during contemporary open heart surgery is poorly studied. Current understanding of the biological impact of cardiac surgery focuses on the surgical aggression itself together with contact activation of inflammatory cascades by the extracorporeal circulation (ECC), both promoting various degrees of a systemic inflammatory response syndrome (SIRS).

Methods and FindingsWe prospectively collected data on GME in the ECC circuit according to a quality control protocol during a 12-month period at our institution. Bubbles were measured means of a last generation multi-channel ultrasound measuring unit (BCC300, Gampt GmbH, Meerseburg, Germany) upstream of the arterial line filter. For analysis, bubbles were separated in three size categories: small (S) (10-40 {micro}m), medium (M) (41-200 {micro}m) and large (L) (201-2000 {micro}m). Small bubbles were considered as noise and excluded. A total of 58 out of 70 open heart procedures were included in the final evaluation performed on 58 patients (45 males, 13 females, mean age 66 {+/-} 9 years). Patient baseline data, type of procedure and perfusion data were retrieved. Preoperative treatment with beta-blockers, ACE-inhibitors, calcium-antagonists and statins was considered. Postoperative SIRS was identified according to modified SIRS and qSOFA criteria.

A variably high amount of GME was detected (mean count 847 {+/-} 2560), we focused on M-sized GME (mean count 820 {+/-} 2546, mean volume 233 {+/-} 730 nL). A total of 22 patients (38%) developed SIRS. To account for differences between patient groups (SIRS-/ SIRS+) propensity score (PS) matching was performed on the presence of M-bubbles at or above the 75th percentile (count and volume). The impact of such GME on the development of SIRS was statistically highly significant, as shown by the corresponding average treatment effects (ATE).

ConclusionsSignificant GME was associated with postoperative SIRS after cardiac surgery in our setting. This novel finding warrants further confirmation.

labels: cardiovascular medicine


sentences: Waning of Vaccine-Conferred Protection against SARS-CoV-2 Infection: Matched Case-Control Test-Negative Design Study in Two High-Risk Populations To distinguish waning of vaccine responses from differential variant protection, we performed a test-negative case-control analysis during a Delta variant-dominant period in Californias prisons. We found that infection odds increased each 28-day period post-vaccination, reaching 3.4-fold (residents) to 4.7-fold (staff) increased odds of infection after 180 days.


sentences: Inflammation in children with chronic kidney disease linked to gut dysbiosis and metabolite imbalance Chronic kidney disease (CKD) is characterized by a sustained pro-inflammatory response. The underlying mechanisms are incompletely understood, but may be linked to gut dysbiosis. Dysbiosis has been described in adults with CKD; however, comorbidities limit CKD-specific conclusions. We analyzed the fecal microbiome, metabolites and immune phenotypes in children at three different CKD stages (G3-G4, G5 (hemodialysis), after kidney transplantation) and healthy controls. Serum TNF- and sCD14 were stage-dependently elevated, indicating inflammation and gut barrier dysfunction. We observed microbiome alterations in CKD, including a diminished production of short-chain fatty acids. Bacterial tryptophan metabolites were increased in CKD. CKD serum activated the aryl hydrocarbon receptor and stimulated TNF- production by monocytes, corresponding to a shift towards intermediate/non-classical monocytes. Unsupervised T cell analysis revealed pro-inflammatory shifts in MAIT and Treg cells. Thus, gut barrier dysfunction and microbial metabolites exacerbate inflammation and may therefore contribute to the increased cardiovascular burden in CKD.


sentences:
Impact of COVID-19 symptoms on social aspects of life of female long haulers: A qualitative study IntroductionPersistent COVID-19 symptoms (long COVID) may bring numerous challenges to long haulers social lives. Women may have to endure more profound impacts given their social roles and existing structural inequality. This study aims to explore the impacts of long COVID on various aspects of social life among female long haulers.

MethodsWe conducted 15 semi-structured interviews with female long haulers in the United States purposely recruited from Facebook groups, Slack groups, and organization websites. The interviews were audio recorded after appropriate consent and transcribed verbatim. Inductive approach was applied in thematic analysis, which consists of six stages: becoming familiar with data, developing initial codes, extracting themes, refining themes, labeling themes, and reporting. The MAXQDA software was used in data analysis.

ResultsPersistent COVID-19 symptoms negatively affected female long haulers social lives in many aspects including physical function, financial security, social relationship, conflict of social roles, and social stigma. Physical limitations changed their body image. Social isolation and work-family conflicts caused huge stress. They experienced internalization of stigma and job insecurities. Shifting to new methods of communication, especially social media may buffer the negative effects of social isolation because of long COVID.

ConclusionExisting policies and intervention programs need to be adapted to address the challenges and barriers that long haulers face in returning to normal social life, especially for females. Tailored social life-related recommendations and social support are needed for female long haulers.